Nova Pharmaceutical, Inc
31712 Casino Drive Suite 7B
Lake Elsinore, Ca 92530
909-245-4657 Fax 909-245-8339
August 27, 1999
The Securities and Exchange Commission
450 5th Street North West
Washington D.C. 20549
To Whom It May Concern:
Nova Pharmaceutical, Inc is hereby withdrawing the Form 10-SB filed on June 30,
1999. The file number is 000-26549.
Nova will re-file the Form 10-SB with June 30, 1999 financial statements and
respond appropriately to the issues raised by SEC Comments in their letter dated
July 28,1999. The purpose for this change is to provide Nova time to
appropriately respond to the comments and to provide more current financial
data.
Should you have any questions, please call our Chief Financial Officer Bob
Eggering at 909-245-4657. Thanks for your consideration.
Sincerely:
/S
Ralph Mann
President
